Rimonabant for overweight and "metabolic syndrome": The attempt to supersize disease and risk by pharmaceutical marketing

Rita Banzi, Lorenzo Moja, Ivan Moschetti, Alessandro Liberati, Gian Franco Gensini, Roberto Gusinu, Andrea A. Conti

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1-4
Number of pages4
JournalInternal and Emergency Medicine
DOIs
Publication statusPublished - 2008

ASJC Scopus subject areas

  • Emergency Medicine
  • Internal Medicine

Cite this